Santana et al. studied the effect of Enolase-1 (ENO1) in ovarian cancer cells and observed that decreased expression of ENO1 promoted glucose accumulation, induced senescence, increased the p53 protein levels, and promoted cisplatin resistance of ovarian cancer cells [20]. Here, TP53 is linked to ovarian carcinoma.